Botulinum toxin therapy
搜索文档
AEON Biopharma(AEON) - Prospectus(update)
2024-06-01 04:03
As filed with the Securities and Exchange Commission on May 31, 2024 Registration No. 333-274094 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 4 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AEON Biopharma, Inc. (Exact name of registrant as specified in its charter) Delaware 2834 85-3940478 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) 5 Park Plaza, Suite ...
AEON Biopharma(AEON) - Prospectus(update)
2024-04-02 18:07
Table of Contents As filed with the Securities and Exchange Commission on April 2, 2024 Registration No. 333-274094 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 3 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AEON Biopharma, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 2834 85-3940478 (Primary Standard Industrial Classification Code Number) 5 Park Plaza, Suite ...
AEON Biopharma(AEON) - Prospectus(update)
2023-11-23 10:48
Table of Contents As filed with the Securities and Exchange Commission on November 22, 2023 Registration No. 333-274094 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AEON Biopharma, Inc. (Exact name of registrant as specified in its charter) Delaware 2834 85-3940478 (Primary Standard Industrial (I.R.S. Employer Identification No.) Classification Code Number) 5 Park Plaza, Suite 1750 Irvine, Californ ...
AEON Biopharma(AEON) - Prospectus(update)
2023-10-21 09:46
Table of Contents As filed with the Securities and Exchange Commission on October 20, 2023 Registration No. 333-274094 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AEON Biopharma, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 2834 (Primary Standard Industrial Classification Code Number) 85-3940478 (I.R.S. Employer ...